Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2026
Filed with HKEX · Stock code 1477 · · 10 pages · English
Summary by 6ix AI
It confirms the total authorized share capital and provides details on issued shares and treasury shares. The report indicates that there were no changes in the number of issued or treasury shares during the month. Additionally, it confirms compliance with public float requirements as per the relevant exchange rules.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Ocumension Therapeutics on 6ix
Earlier from Ocumension Therapeutics
- 2026 Interim Report
- OcuMension acquires rights to Alcon eye drops in exchange for a 16.7% equity stake, signaling the commencement of comprehensive strategic relationship
- OcuMension (01477.HK) Invests Over RMB 123.8 Million in Research, Technology and Self-development Progress in Tandem, Main Product Sales Show Comprehensive Growth
- Ocumension Therapeutics Announces 2023 Interim Results
- Ocumension Therapeutics Announces 2022 Annual Results
Later from Ocumension Therapeutics
All Ocumension Therapeutics news releasesFollow Ocumension Therapeutics into a list and get an email when it puts out news.
Follow Ocumension Therapeutics